Pfizer, a Rs. 2,000 crore plus MNC, has achieved net profit growth of 40 per cent during the third quarter ended December 2017 to Rs. 87.24 crore from Rs.62.37 crore in the similar period of last year mainly due to reduction in employees costs and other adjustments. Its net sales declined by 10.5 per cent to Rs. 456.54 crore from Rs. 510.23 crore due to
discontinuation of Corex cough syrup and transition/divesture of certain brands. The figures for sales are not strictly comparable as the current period sales are net of GST and last year sales were net of excise duty. Further, last year figures of net profit includes exceptional items of Rs. 19.04 crore generated from sales of properties and other.
Pfizer scrip touched to its yearly peak level at Rs. 2,221 on BSE today and closed higher by Rs. 75.05 to Rs. 2,185.85.
For the nine months period ended December 2018, Pfizer's sales declined by 8.1 per cent to Rs. 1,460 crore from Rs. 1,589 crore in the corresponding period of last year. Its net profit declined by 4.9 per cent to Rs. 255.56 crore from Rs. 268.74 crore mainly due to exceptional income of Rs. 130.43 in the last period. EPS worked out to Rs. 55.86 as compared to Rs. 58.74 in the last period.
discontinuation of Corex cough syrup and transition/divesture of certain brands. The figures for sales are not strictly comparable as the current period sales are net of GST and last year sales were net of excise duty. Further, last year figures of net profit includes exceptional items of Rs. 19.04 crore generated from sales of properties and other.
Pfizer scrip touched to its yearly peak level at Rs. 2,221 on BSE today and closed higher by Rs. 75.05 to Rs. 2,185.85.
For the nine months period ended December 2018, Pfizer's sales declined by 8.1 per cent to Rs. 1,460 crore from Rs. 1,589 crore in the corresponding period of last year. Its net profit declined by 4.9 per cent to Rs. 255.56 crore from Rs. 268.74 crore mainly due to exceptional income of Rs. 130.43 in the last period. EPS worked out to Rs. 55.86 as compared to Rs. 58.74 in the last period.